Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-259852
Filing Date
2024-11-15
Accepted
2024-11-15 16:29:57
Documents
2
Group Members
FORBION GROWTH MANAGEMENT B.V.FORBION GROWTH OPPORTUNITIES FUND I COOPERATIEF U.A.FORBION IV MANAGEMENT B.V.FORGROWTH NAP B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d863823dsc13da.htm SC 13D/A 94987
2 EX-99.7 d863823dex997.htm EX-99.7 8955
  Complete submission text file 0001193125-24-259852.txt   105749
Mailing Address GOOIMEER 2-35 NAARDEN P7 1411 DC
Business Address GOOIMEER 2-35 NAARDEN P7 1411 DC 31 356993000
Forbion Capital Fund IV Cooperatief U.A. (Filed by) CIK: 0001823747 (see all company filings)

EIN.: 981445896 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Subject) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93833 | Film No.: 241468265
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)